Indolent Non-hodgkin Lymphoma

Explore clinical trials studying Indolent Non-hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

24 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Indolent Non-hodgkin Lymphoma trial results

Active, Not Recruiting

NCT03749018

Conditions: Aggressive Non-Hodgkin Lymphoma, Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma, Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma, +22 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

Active, Not Recruiting

NCT04323956

Conditions: Ann Arbor Stage II Diffuse Large B-Cell Lymphoma, Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma, +22 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

Active, Not Recruiting

NCT03884998

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, +26 more
Locations: City of Hope Medical Center Duarte, California, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

OHSU Knight Cancer Institute Portland, Oregon, United States

Active, Not Recruiting

NCT04464200

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Burkitt's Lymphoma, +41 more
Locations: Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Cancer Commack - Suffolk (Limited Protocol Activities) Commack, New York, United States